TP53 and cancer: Consistent with the hypothesis that p53 activity suppresses cancer initiation and progression, p53+/m mice exhibit decreased cancer incidence (6%) in comparison to wild-type control mice (45%), although this incidence may be underrepresented due to decreased longevity (Tyner et al, 2002).